COIL Share Price Performance
UK£0
-0.18 (-100.00%)
Price UK£0
Share Pricen/a
Coiled Therapeutics plc Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
COIL Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Coiled Therapeutics plc Key Details
About COIL
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Coiled Therapeutics plc, a clinical stage oncology company, develops precision oncology therapies. It develops AO-252, a TACC3 inhibitor that is in Phase I clinical trials; and STAT-6 siRNA program, which is in preclinical trials for treating immunology indications. The company is based in London, United Kingdom.
